Your session is about to expire
← Back to Search
Vaccine
Sucrose for Vaccination Pain Management
Phase 3
Waitlist Available
Led By Anna Taddio, PhD
Research Sponsored by Anna Taddio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
healthy infants receiving rotavirus vaccine in conjunction with primary immunizations in the first 6 months of life
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after vaccination in 1 minute
Awards & highlights
Study Summary
This randomized trial will compare the analgesic effectiveness of oral rotavirus vaccine to sugar water for reducing vaccine injection pain in infants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after vaccinations in 1 minute
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after vaccinations in 1 minute
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Fetal Distress
Other outcome measures
Safety
Satisfaction
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SucroseExperimental Treatment1 Intervention
Sucrose prior to vaccine injections
Group II: RotavirusActive Control1 Intervention
Rotavirus prior to vaccine injections
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sucrose
FDA approved
Find a Location
Who is running the clinical trial?
Anna TaddioLead Sponsor
Anna Taddio, PhDPrincipal InvestigatorUniversity of Toronto
16 Previous Clinical Trials
18,560 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger